Trial intelligence / Profile preview

Evaluation of PuraStat for hemostasis during laparoscopic endometrioma surgery

jRCTs032220355Active, not recruiting

Sponsor
3-D Matrix
Start
Feb 2023
Modality
Peptides
Countries
1
01

Overview

Open-label trial of PuraStat in endometrioma (2 arms), sponsored by 3-D Matrix. Primary endpoints: Number of times of electrocoagulation during surgery, Cumulative time of electrocoagulation during surgery and 1 more. Started Feb 2023; status: active, not recruiting.

02

Drugs

PuraStat
03

Conditions

endometrioma

Beyond the preview

Go deeper on jRCTs032220355.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCTs032220355.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call